Holen Sie sich die Stockscreener-App
25.94
8.85%
-2.52
Handel nachbörslich:
25.94
Schlusskurs vom Vortag:
$28.46
Offen:
$28.09
24-Stunden-Volumen:
2.12M
Relative Volume:
1.38
Marktkapitalisierung:
$1.66B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-218.28M
KGV:
-7.2452
EPS:
-3.5803
Netto-Cashflow:
$-186.55M
1W Leistung:
-14.70%
1M Leistung:
-13.93%
6M Leistung:
+2.49%
1J Leistung:
-40.80%
1-Tages-Spanne:
$25.10
$28.67
1-Wochen-Bereich:
$25.10
$30.46
52-Wochen-Spanne:
$18.53
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
Firmenname
Vera Therapeutics Inc
Sektor
Branche
Telefon
650-770-0077
Adresse
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Vergleichen Sie VERA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
25.94 | 1.82B | 0 | -218.28M | -186.55M | -3.5803 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-16 | Eingeleitet | BofA Securities | Buy |
| 2025-08-04 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2025-01-28 | Eingeleitet | Goldman | Buy |
| 2024-11-21 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-01-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-12-18 | Eingeleitet | Raymond James | Outperform |
| 2023-11-10 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-16 | Eingeleitet | Guggenheim | Buy |
| 2023-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-01-04 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-07-12 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-19 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten
Applying sector rotation models to Vera Therapeutics Inc.Short Setup & Low Drawdown Momentum Ideas - newser.com
Building trade automation scripts for Vera Therapeutics Inc.Weekly Profit Analysis & Verified Swing Trading Watchlists - newser.com
Can Vera Therapeutics Inc. hit a new high this monthJuly 2025 Reactions & Technical Pattern Alert System - newser.com
Is Vera Therapeutics Inc. still worth holding after the dipMarket Activity Recap & Community Verified Watchlist Alerts - newser.com
Historical volatility pattern of Vera Therapeutics Inc. visualized2025 Earnings Impact & Daily Volume Surge Trade Alerts - newser.com
Can Vera Therapeutics Inc. stock maintain operating marginsJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com
How high can Vera Therapeutics Inc. stock goJuly 2025 PreEarnings & Fast Entry High Yield Tips - newser.com
Vera Therapeutics Inc. stock chart pattern explainedWeekly Stock Analysis & Weekly Chart Analysis and Trade Guides - newser.com
What MACD signals say about Vera Therapeutics Inc.July 2025 Analyst Calls & Precise Buy Zone Tips - newser.com
How Vera Therapeutics Inc. stock benefits from strong dollar2025 Market Outlook & Real-Time Market Trend Scan - newser.com
Ranking Vera Therapeutics Inc. among high performing stocks via toolsMarket Growth Report & Low Volatility Stock Recommendations - newser.com
Pivotal Week Ahead for Vera Therapeutics Investors - AD HOC NEWS
Applying Wyckoff theory to Vera Therapeutics Inc. stockJuly 2025 Recap & Safe Capital Growth Stock Tips - newser.com
How to build a custom watchlist for Vera Therapeutics Inc.Weekly Stock Recap & Weekly Stock Performance Updates - newser.com
How Vera Therapeutics’ (VERA) Phase 3 IgA Nephropathy Data Spotlight May Influence Investor Sentiment - Sahm
Vera Therapeutics (VERA) to Release Earnings on Thursday - MarketBeat
How to interpret RSI for Vera Therapeutics Inc. stockJuly 2025 EndofMonth & High Conviction Buy Zone Picks - newser.com
Will Vera Therapeutics Inc. stock continue dividend increasesWeekly Risk Report & Verified Entry Point Signals - newser.com
Is Vera Therapeutics Inc. stock a buy before product launchesSell Signal & Reliable Entry Point Alerts - fcp.pa.gov.br
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):